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 Outreach needle and syringe program (NSP) model is as effective as facility-based NSP 
in reducing the harm associated with drug injection.
 The outreach model is even more effective in reducing the lending of syringes.
 Both NSP models increase the rate of HIV testing.
 We found that less than one-quarter of people who inject drugs have access to NSP 
services through outreach services, which need to be scaled up.
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Background: Needle and syringe programs (NSP) are widely used to reduce harms associated 
with drug injection. This study assessed the effect of facility-based (on-site services at drop-in 
centre) and outreach NSP model on injection risk behaviours.
Methods: We used self-reported data from 455 people who inject drugs (PWID) during 2104 in 
Kermanshah, Iran to measure demographic characteristics and risk behaviors. We also used both 
self-reported and program data to identify their main source of injection equipments. 
Accordingly, we grouped participants into three sub-groups: facility-based NSP users, outreach 
NSP users and non-users (comparison group). Using coarsened exact matching, we made the 
three groups statistically equivalent based on age, place of residence, education and income; and 
compared them regarding the proportion of borrowing or lending syringes/cookers, reusing 
syringes and recent HIV testing.
Results: Overall, 76% of participants reported any NSP service use during the two months prior 
to the interview. Only 23% (95%CI: 17-27) reported the outreach NSP as their main source of 
syringes. Using facility-based NSP significantly decreased recent syringe borrowing (OR: 0.27, 
95%CI 0.10-0.70), recent syringe reuse (OR 0.38, 95%CI 0.23-0.68) and increased recent HIV 
testing (OR 2.60, 95%CI 1.48-4.56). Similar effects were observed among outreach NSP users; 
in addition, the outreach NSP model significantly reduced the chance of lending syringes (OR: 
0.31, 95%CI 0.15-0.60), while facility-based did not (OR: 1.25, 95%CI 0.74-2.17).     
Conclusion: We found that outreach NSP model is as effective as facility-based NSP in reducing 
injection risk behaviours and in increasing the rate of HIV testing. The outreach model is even 
more effective in reducing the lending of syringes to other PWID in compare to facility-based 
NSP model. Scaling up outreach NSP is an effective intervention to further reduces the 
transmission of HIV via needle sharing. 
Keywords: People who inject drugs, matching, needle and syringe programs, injection risk 
behaviours












Recently UNAIDS/WHO reported that about 270,000 people are living with HIV in the Middle 
East and North Africa (1). In Iran, HIV prevalence is low in the general population (less than 
1%), while concentrated among people who inject drugs (PWID) (2, 3). There are approximately 
170,000-230,000 PWID in Iran, of whom, 15% infected with HIV (4, 5). Over two-third of all 
new identified HIV cases have been attributed to unsafe injection (2, 6-8). To reduce the risk and 
harms associated with injection, Needle and Syringe Programs (NSP) have been developed and 
implemented in Iran since 2002. NSP is delivered through specific facilities, called Drop-in 
Centres (DIC) to those who have access to the services and by outreach teams to those PWID 
who are off services (6, 9, 10).
NSP outreach is a community-based intervention strategy, which reaches PWID at the venues 
where they live, socialize, buy or inject drugs (11). The DICs and outreach NSP provide sterile 
needle and syringe services, deliver training on safe injecting practices and overdose prevention. 
They also provide condom and safe sex education (12, 13). Safe injection kits distributed through 
NSP consisted of 3-4 syringes, extra 3-4 needles, sterile water vials, and alcohol pads at every 
visit for anyone self-reported as injecting drug user. In outreach, the same strategy is being 
implemented (7). The two models of NSP services are the main sources of access to syringe and 
needle in Iran (3). People who inject drugs can use both on-site and outreach NSP services, 
whatever they have access too (14).
The effectiveness of the two models of NSP has not been evaluated in Iran. The cost for 
establishing and maintaining a new NSP site is much higher than adding-on or expanding an 
outreach-based NSP to an existing Drop-in Centre or a health facility. Some NSP sites have their 
focus on on-site services and less interested to provide outreach NSP. Part of this is the lack of 
knowledge or believes on the effectiveness of outreach activities; the big question is that are they 
truly reduce the harm and injection risk behaviours when delivered at the community. The 
objective of this study is to evaluate the effectiveness of the two NSP models, on-site services at 
DICs and outreach-based NSP, on injecting risk behaviors of PWID in Kermanshah, an urban 
setting in southwestern part of Iran. Kermanshah is the first place where HIV epidemic was 
emerged in Iran and triggered the national response to HIV.












We used data from a cross-sectional study of PWID in Kermanshah. Study participants were 
recruited from the community and NSP sites between September and December 2014. PWID 
from NSP sites were recruited by convenient sampling among the eligible PWID attended the 
facility, whereas other PWID were recruited by outreach and peer-referral. The outreach team 
regularly attended venues where PWID congregated frequently, approached the PWID to check 
the eligibility and, if agreed, recruited them to the study after consenting. They were also asked 
to refer their peers to the study by distributing referral coupons.
The study inclusion criteria were:
 Males aged over 18 years 
 Self-reported drug injection within the last month prior to the interview
 Willingness to provide written consent to participate in the study.
We collected data through face-to-face interviews. The questionnaire consisted of five sections 
including demographic information, the type of drug injected the most, duration of drug use and 
injection, frequency of injection, risk behaviours such as sharing (borrowing or lending) 
syringes/needles and cookers, reuse of syringes and the number of injecting partners they have 
shared syringes/needles with during the month prior to the interview. We also asked whether the 
participant has tested for HIV in the last 12 months. We validated the content of our 
questionnaire with inputs from eight experts in behavioural science, epidemiology and harm 
reduction areas. 
Our primary exposure was whether study participants have used on-site or outreach NSP services 
as their main source of syringes in the last two months prior to the interview. We measured it 
based on the self-reported data, and then validated by checking the sites’ charts and outreach log 
books at the study site. More specifically, as a rough cutoff, if a participant reported NSP site as 
the source of 70% or more of their syringes, they have been considered as on-site NSP users; and 
if they have been receiving most (70% or more) of syringes from outreach services, we assigned 
them to outreach-based NSP users’ group. Those who have reported neither on-site nor outreach 
NSP as their main (70% or more) source of syringes were considered as NSP non-users group. In 
case of discrepancy, we allocated the participants based on the charts and data in the logbook.
No identifying information was collected. During the consent procedure, participants were 
provided sufficient information about the study objectives, risk and benefits of participating in 
the study, and the right that they can withdraw from the study at any time without any penalty. 
The study protocol and all the procedures were reviewed and approved by the Research Ethics 
Committee of the Kerman University of Medical Sciences (Ethics Code: k/93/204).











In this paper, we applied a novel technique, Coarsened Exact Matching (CEM), to match the 
groups, outreach and facility-based NSP users and non-NSP users based on certain covariates 
and made statistically equivalent comparison groups to estimate the effect of the two NSP 
models on injection risk behaviours. The CEM created a comparable sub-sample of the three 
subgroups based on age, place of residence, income and education level. CEM is a statistical 
matching technique, used to improve causal inferences of observational studied (17). CEM 
attempts to control for the potential confounding influence of ‘pre-exposure’ covariates on the 
outcome of interest, by matching ‘exposed’ cases with ‘non-exposed’ cases that are 
approximately similar to them with regard to covariates (18). In our study, the CEM approach 
allowed us to designate a counterfactual for each participant in the exposed group, i.e. outreach-
based NSP, and mimic a randomized clinical design. The CEM approach is recommended 
especially when an experimental design is not feasible (19). The effect of public health 
programs, like NSP, which are part of ongoing services, are hard and unethical to be assessed by 
randomization controlled trials (which provide the highest quality of evidences). We chose CEM 
over other matching techniques, such as propensity score matching, to achieve balanced groups, 
reduce the need for multiple iterations and re-matching, and maximize the number of possible 
matches in our sample. Also, it was not known to us what are the predictors for using outreach or 
on-site NSP, which is crucial to apply a propensity matching analysis (20, 21).
Using CEM, we allocated every study participant into one of the specified set of strata in which 
all were exactly matched on a set of coarsened or matched variables. Matched members were 
then assigned a weight specific to their stratum and representative of the proportion of all 
members present in that stratum (20). Then, we calculated a statistical measure called L1 
distance. L1 varies between 0 and 1 and values close to zero indicate that the matching is perfect 
and ensure the comparability of the two groups (15). We calculated the L1 before and after 
applying CEM, and we observed that L1 decreased from 0.43 to 0.00003 after coarsened exact 
matching. It was reassuring that the imbalance between the two comparison groups is very small 
and can be ignored. Given the matched subgroups, we reported the descriptive statistics for the 
pool sample and matched sub-sample. We applied logistic regression models to estimate the 
effect of outreach and facility-based NSP on injection risk behaviours. The effects were reported 
as odds ratio (OR) and 95% confidence interval (CI). All data analysis were performed using 
STATA v.11.












Characteristics of study participants
A total of 455 men who injected drugs participated in this study. The characteristics of 
participants in pooled (unmatched) and matched sub-sample are presented in table 1. Matched 
sample (n = 278) had a mean age ± standard deviation (SD) of 34.5 ± 8.6 (range 19-58) years.
The majority of respondents were under 30 years old (54.6%). Also, 61.8% of participant had 
less than a high school education, 77.3% were single, 52.5% lived with their families, and 87.3% 
had monthly income less than $150. About 88.5% reported their first drug use, and 76.4% had 
their first injection under the age of 25 years old.
Behaviors of study participants and estimates of NSP outcomes
Overall, 76% of study participants reported any NSP service use during the two months prior to 
the interview. And only 23% (95%CI: 17-27) have used outreach NSP as their main source of 
their syringes.  
Table 2 shows NSP outcomes in matched and unmatched study sub-samples. Only matched 
results are discussed here. Regarding needle sharing behaviors, about 30% of respondents 
reported “ever borrowing a syringe” and 12% reported “recent borrowing a syringe”. Similarly, 
13% of participants reported “recent lending a used syringe” to other PWID. Ever and recently 
borrowing or lending a cooker was more commonly reported by participants (68% and 53%, 
respectively). The majority of participants (86%) reported “reuse of their own syringes” in the 
month prior to the interview. The mean number of injecting partners whom the study participants 
had shared syringe/needle or cooker with was 2.31±1.45. The majority of PWID (85.3%) 
reported “an HIV test in the past 12 months”.
In Table 3, we present the effect of the two NSP models, facility-based and outreach, on different 
injection risk behaviours in the pooled and matched sub-samples. In the matched sub-sample, 
PWID who used facility-based NSP services were less likely to report borrowing syringes in past 
month (OR: 0.27, 95%CI: 0.10-0.70, P-Value: 0.04), in compare to non-NSP users. Likewise, 
those who used the NSP outreach services had reported less recent syringe borrowing (OR: 0.40, 
95%CI: 0.28–0.81, P-Value: 0.01). 
Regarding recent syringe lending, the outreach NSP was significantly effective (OR: 0.31, 
95%CI 0.15-0.60, P-Value: 0.02), while facility-based NSP was not (OR: 1.25, CI95% 0.74–
2.17). Own syringe reuse was reported less frequently in both the facility-based group (OR: 0.38, 
CI95% 0.23-0.68,P-Value: 0.03) and outreach (OR: 0.54, 0.30-0.92,P-Value: 0.02). Recent 
cooker sharing was reported less among facility-based NSP service users (OR: 0.86, 95%CI 0.4-
1.82, P-Value: 0.30) and outreach NSP users (OR: 0.63, 95%CI 0.47-3.38, P-Value: 0.23), 
however both were not statistically significant. Both facility-based and outreach NSP programs 
increased the chance of recent HIV testing by 2.60 and 2.45 times, respectively.












We found that outreach NSP is as effective as facility-based outreach in decreasing the use of 
borrowing syringes, reuse of own used syringes and being tested for HIV. Outreach NSP shown 
promising effect on reducing the lending syringe behaviours than the facility-based NSP.
Effectiveness of needle/syringe programs in reducing needle and syringe sharing among PWID 
has been shown in previous studies (13, 22-24). There are several methods for distribution, sale 
or exchange of injecting equipment such as conventional NSPs (Facility-based NSP), pharmacy-
based distribution and outreach programmes. NSP services through outreach can be provided at 
locations and times that are convenient for PWID and so increase their access to NSP services 
(25). It also improves the coverage of NSP service as some PWID do not use NSP services at the 
facilities due to structural and cultural barriers (26).
There are limited data on the effectiveness of different delivery method of NSP and their effect 
on preventing HIV risk behaviours (27). We found that majority of the PWID have access and 
use either of the NSP delivery models. However, only one-quarter of them reported outreach 
NSP as their main source of injection equipments. Obviously there is a room to improve and 
scale up the NSP services through outreach. The results of matched analysis in our study showed 
that injection high-risk behaviours are relativity common in PWID, no matter if they have access 
to facility-based or outreach NSP services. Our results are consistent with the results reported in 
other studies (5, 28, 29). In 2010, Sajadi et al. reported that 12.6% of PWID in Iran shared 
syringes and needle (28). We found that the most common injection equipment that shared was 
cooker. High rate of cooker sharing also reported by other studies. In study of PWID in Wales 
(UK) in 2010, paraphernalia (cooker) sharing was reported by 67% of participants (30). Zamani 
et al in 2010 reported that %32 of injecting drug users in Isfahan share cooker (31).
We found both facility-based and outreach NSP models are effective in reducing the injection 
risk behaviours. Putting NSP in scale, increasing the number of distributed syringes/needles, 
scaling up second-hand distribution, expanding the coverage of services and establishing NSP 
services at high-risk neighbourhoods and venues where PWID gathered has been shown to 
reduce the risk behaviours (32). Such comprehensive intervention packages have been shown to 
be effective in developed settings such as San Francisco and Montreal where the risk of HIV 
transmission among PWID decreased over time by scaling up NSP services (13, 33). In 2007, 
Islam et.al. demonstrated that fixed-site NSP and outreach programs are effective strategies to 
reach, refer and provide services that can lead to reduced HIV-related risk (25). Rhodes (2004) 
who studied injecting equipment sharing among PWID in Russia, showed that PWID who 
reported NSP or outreach as their main source of new needles and syringes were less likely to 
share compared to those obtaining them from a pharmacy or shop (12).
We found that not only NSP programs improved injection risk behaviours, but also, use of NSP  
either on-site or outreach-based was associated with higher uptake of HIV testing. Ever HIV 











testing was reported as low as 60% in 2004 among 105 injecting drug users recruited in Tehran 
(7) and as 49.8% in recent national PWID surveillance survey in 2010 (unpublished data). Such 
outreach programs should be considered as an opportunity to provide condoms, information, 
refers to services, providing community-based HIV testing and counselling, and overall 
improving health of PWID (34). In a study in southern China, the authors found that referral for 
HIV testing is an effective strategy and can increase the uptake of HIV testing among PWID 
(31). 
We found that outreach NSP was more effective in reducing the lending of syringes. In 2002, 
Obadia showed that Outreach users were significantly less likely to share syringes, cookers and 
solutions during the previous six months compared to non-users(35). Also Miller et al reported 
that needle lending was lower among outreach users than participants who reported using the 
fixed-site NSP and pharmacy-base NSP (36). The lower rates of syringe lending in outreach 
users compared to fixed-site users can be explained by higher injection frequency in outreach 
users that also reported in other studies (37). We found that the injection rate (per week) of those 
using outreach NSP was higher than users of NSP services at facilities. One hypothesis could be 
that as the numbers of distributed syringes per visit are the same in both NSP models, outreach 
NSP users are less willing to lend their injection equipments. Another explanation is that during 
the NSP outreach, all PWID who were presented at the venue had received syringes and other 
injection equipments, all together and at about the same time. So, everybody at the site have 
received sufficient number of syringes and therefore, there was no peer-presser to lend injection 
equipments. In contrast, in the facility-based model, the approach was more like an individual-
based approach and one person served at a time; the client who had received the injection 
equipments at the facility, might be asked later at the venues (peer-presser) to share their 
injection equipments. 
A limited number of PWID (less than one-quarter) have access to NSP services through outreach 
services. Given that the effect of outreach NSP is equivalent to on-site NSP services, scaling up 
the outreach services to improve the coverage of NSP services is one of the effective strategies to 
reach the population of injecting drug users in Kermanshah and reduce the injection transmission 
of HIV in this setting. 
There are some limitations to our study findings. We used a mixed method of recruitment 
strategies to locate and recruit eligible participants to our study; our sample diversity might be 
comprehensive enough for Kermanshah, however, it is not a truly random sample of our target 
PWID population. Like any other observational studies, we can only report the association of 
program exposure with high-risk behaviours. Furthermore, our data were based on participants 
self-report and therefore may be subject to recall bias and social desirability bias (38). We made 
the two groups comparable based on matching of age, income, education and city residence, 
however we could not account for other factors such as distance to NSP facilities, availability of 
methadone maintenance therapy and other individual factors.












Our analysis demonstrates that current NSP model in Iran is effective. We found that outreach 
NSP is as effective as facility-based NSP in reducing the harm associated with drug injection and 
is even more effective in reducing the lending of syringes to other PWID. Sharing cookers is 
common and current NSP models in Iran have limited effects on it. Both models of NSP should 
be scaled up in terms of quality and coverage of target PWID to see their promising impacts on 
HIV epidemic in Iran.
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Table 1: Characteristics of participants in the pooled (total) and matched subsample of people who 
inject drugs, Kermanshah, 2014






































































































Table 2: Behavioral outcomes in the pooled (total) and matched subsample of people who inject drugs, 
Kermanshah, 2014
Behavioral Outcome Pooled (N=455), N(%) Matched (N=278), N(%)
Ever borrowing a syringe 152(34.2) 84(30.2)
Borrowing a syringe in the past month 60(14.2) 31(12.3)
Ever lending a used syringe 145(32.4) 71(26.3)
Lending a used syringe in the past month 58(13,7) 36(13.4)
Ever borrowing or lending a cooker 329(72.4) 186(68.2)
Borrowing or lending a cooker in the past month 253(56.5) 137(53.2)
Reuse own syringes in the past month 397(88.2) 239(86.1)
Received an HIV test in the past 12 months 390(85.2) 237(85.3)
Number of injecting partners whom shared 



















Table 3: The odds ratios for the association of the two needle and syringe distribution models with some 
injection risk behaviours in the pooled (total) and matched subsample of people who inject drugs, 
Kermanshah, 2014
Behavioral outcomes Pooled sample OR 
(CI%95)
Match sample         
OR (CI%95)


















































*Reference group, **Significant at p < 0.05. The matched subsample was made by considering age, place of residence, 
education and income.
